281 related articles for article (PubMed ID: 32229283)
1. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
[TBL] [Abstract][Full Text] [Related]
2. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.
Tahir N; Madni A; Correia A; Rehman M; Balasubramanian V; Khan MM; Santos HA
Int J Nanomedicine; 2019; 14():4961-4974. PubMed ID: 31308666
[No Abstract] [Full Text] [Related]
3. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Akhter MH; Kumar S; Nomani S
Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
[No Abstract] [Full Text] [Related]
4. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications.
Tahir N; Madni A; Balasubramanian V; Rehman M; Correia A; Kashif PM; Mäkilä E; Salonen J; Santos HA
Int J Pharm; 2017 Nov; 533(1):156-168. PubMed ID: 28963013
[TBL] [Abstract][Full Text] [Related]
6. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
7. Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.
Gdowski A; Johnson K; Shah S; Gryczynski I; Vishwanatha J; Ranjan A
J Nanobiotechnology; 2018 Feb; 16(1):12. PubMed ID: 29433518
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer.
Yildiz T; Gu R; Zauscher S; Betancourt T
Int J Nanomedicine; 2018; 13():6961-6986. PubMed ID: 30464453
[TBL] [Abstract][Full Text] [Related]
9. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z
Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952
[TBL] [Abstract][Full Text] [Related]
10. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
11. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
12. Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake.
Patel M; Desai A; Kansara V; Vyas B
AAPS PharmSciTech; 2023 Jun; 24(6):142. PubMed ID: 37353671
[TBL] [Abstract][Full Text] [Related]
13. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma.
Li S; Xu Z; Alrobaian M; Afzal O; Kazmi I; Almalki WH; Altamimi ASA; Al-Abbasi FA; Alharbi KS; Altowayan WM; Singh T; Akhter MH; Gupta M; Rahman M; Beg S
Biotechnol Appl Biochem; 2022 Oct; 69(5):2205-2221. PubMed ID: 34775646
[TBL] [Abstract][Full Text] [Related]
14. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
[TBL] [Abstract][Full Text] [Related]
15. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
[TBL] [Abstract][Full Text] [Related]
16. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
17. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
18. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2018 Sep; 548(1):255-262. PubMed ID: 29969712
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of composite poly(d,l-lactide)/montmorillonite nanoparticles for controlled delivery of acetaminophen by solvent-displacement method using glass capillary microfluidics.
Othman R; Vladisavljević GT; Thomas NL; Nagy ZK
Colloids Surf B Biointerfaces; 2016 May; 141():187-195. PubMed ID: 26852102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
